46 results
S-8
EX-99.1
TAK
Takeda Pharmaceutical Co
25 Jun 20
Registration of securities for employees
6:21am
calendar month following the end of the calendar quarter in which the Award Recipient terminates employment or service by reason of Disability or death … termination of employment with the Company and all Group Companies (a) for any reason other than death, Disability or Cause, and (b) which constitutes
6-K
TAK
Takeda Pharmaceutical Co
7 Sep 21
Current report (foreign)
6:02am
of Specific Lots of Moderna’s COVID-19 Vaccine in Japan
Osaka, Japan, September 7 – Takeda and Moderna have been notified of a death from the recently … is something that we take very seriously. We offer our sincerest condolences to their loved ones.
The additional death occurred on August 12, following
SC TO-T
EX-99
TAK
Takeda Pharmaceutical Co
30 Apr 18
Third party tender offer statement
6:13am
representatives of the signer(s) and shall not be affected by, and shall survive, the death and incapacity of the signer(s). The signer(s) understands … by tendered ADSs.
All authority deemed to be conferred or agreed to be conferred in this ADS Letter of Transmittal shall survive the death or incapacity
6-K
TAK
Takeda Pharmaceutical Co
14 Oct 22
Current report (foreign)
7:36am
, globalization and climate change.1 Severe dengue accounts for about 5% of dengue cases and is a leading cause of serious illness and death among … is a leading cause of serious illness and death among children.14 Baseline blood samples were collected from all individuals participating in the trial
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
30 Nov 22
Current report (foreign)
6:28am
and potentially lead to death if not treated early and appropriately. 3 The incidence of dengue has grown dramatically in recent years, and can … be attributed to factors such as urbanization and climate change. 1 Dengue is also the leading cause of serious illness and death among children and adults
6-K
lrt 0565vtdm2vp3r5w
24 Jun 20
Current report (foreign)
6:07am
6-K
ovjlnscpeojb4 xzeo
8 Jul 21
Current report (foreign)
6:21am
6-K
8dy53ctosw316zy
9 Jun 23
Current report (foreign)
6:03am
6-K
7ld 1fnosvmpk
10 Jun 22
Current report (foreign)
6:00am
SC TO-T
EX-99
4u0ccek jpw6fomv040s
30 Apr 18
Third party tender offer statement
6:13am
6-K
EX-99.1
i4rz56zsqg r0y8nzw57
8 Dec 20
Current report (foreign)
6:01am
6-K
EX-99.1
p3428s8xueg5
21 Nov 19
Current report (foreign)
6:08am
6-K
EX-99.1
gsotf 8d9twmi
14 Nov 19
Current report (foreign)
6:26am
6-K
fxdns7
8 Dec 22
Current report (foreign)
6:46am
6-K
EX-99.1
wmbv2ih lh2ko
23 Aug 22
Current report (foreign)
6:13am
S-8
EX-99.1
oqy a8uwbpp6
29 Jun 22
Registration of securities for employees
6:13am
F-4/A
EX-99.1
j2g4btx0yz9uywx0pn
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
6-K
koyvwz3xo41
12 Feb 21
Current report (foreign)
6:04am
6-K
7aa x4ckwmpkab1auqa
13 Feb 20
Current report (foreign)
6:05am
6-K
pgmdzzjh 7nptwtxx4e
5 Nov 21
Current report (foreign)
6:02am